On March 18, Haitong Securities Company Limited(600837) released the performance express of 2021. In 2021, Haitong Securities Company Limited(600837) achieved an operating revenue of 43.103 billion yuan, a year-on-year increase of 12.78%; The net profit attributable to shareholders of listed companies was 12.827 billion yuan, a year-on-year increase of 17.94%.
From the performance express and annual reports of securities companies released before, the revenue ranking probability of Haitong Securities Company Limited(600837) 2021 will rank second in the industry, second only to Citic Securities Company Limited(600030) ; The net profit ranks third, behind Citic Securities Company Limited(600030) , Guotai Junan Securities Co.Ltd(601211) . In addition, Haitong Securities Company Limited(600837) ‘s roe (weighted average return on net assets) reached 8.09%, up 0.21 percentage points year-on-year.
The reporter noted that Haitong Securities Company Limited(600837) ipo business has performed well this year, which has helped 11 companies such as Tianyue advanced, chuangyao technology, Maiwei biology and adopt shares to issue successfully. It is reported that Haitong Securities Company Limited(600837) focuses on serving the national strategy and the main line of the real economy, and has successfully built a “Haitong brand” in the field of integrated circuits and medical healthP align = “center” the revenue is 43.1 billion yuan, ranking the second in the industry temporarily
On March 18, Haitong Securities Company Limited(600837) released the annual performance express of 2021. In 2021, the company’s operating revenue was 43.103 billion yuan, an increase of 12.78% over the same period of last year; The net profit attributable to shareholders of listed companies was 12.827 billion yuan, an increase of 17.94% over the same period last year. The basic earnings per share is 0.98 yuan.
The performance express shows that by the end of 2021, Haitong Securities Company Limited(600837) total assets were 745314 billion yuan, an increase of 7.38% year-on-year; The owner’s equity attributable to shareholders of listed companies was 163138 billion yuan, a year-on-year increase of 6.31%; The net assets per share attributable to the shareholders of the listed company was 12.49 yuan, an increase of 6.30% year-on-year at the end of 2020.
The announcement shows that in 2021, in the face of the complex macro environment and epidemic situation, Haitong Securities Company Limited(600837) maintain concentration, pay close attention to the main line of serving the national strategy and the real economy, further expand the brand advantages in the fields of integrated circuits and biomedicine through the close linkage of “investment, finance, insurance and research”, make breakthroughs in key business areas and continuously improve the revenue structure. At present, the company has stable businesses, good asset structure and strong liquidity. All risk control indicators meet the requirements of the measures for the management of risk control indicators of securities companies.
From the performance express and annual reports of securities companies released before, the revenue ranking probability of Haitong Securities Company Limited(600837) 2021 will rank second in the industry, second only to Citic Securities Company Limited(600030) ; The net profit ranks third, behind Citic Securities Company Limited(600030) , Guotai Junan Securities Co.Ltd(601211) . In addition, Haitong Securities Company Limited(600837) ‘s roe (weighted average return on net assets) reached 8.09%, up 0.21 percentage points year-on-yearP align = “center” since the beginning of this year, the number of exclusive sponsors has ranked first in the whole market
Since this year, Haitong Securities Company Limited(600837) investment banking has handed over a brilliant report card. According to choice, as of March 19, Haitong Securities Company Limited(600837) has helped 11 companies including Tianyue advanced, chuangyao technology, Maiwei biology and adoptive shares to issue successfully, raising 18.168 billion yuan, of which 10 were exclusively sponsored and lead underwriters by Haitong, ranking first in the whole market.
The reporter learned that Haitong Securities Company Limited(600837) based on the strategic tasks of “launching the service brand of Haitong science and innovation board, helping the high-quality and integrated development of the Yangtze River Delta, and actively promoting the in-depth cooperation with the new port area”, Haitong Securities Company Limited(600837) gave full play to the financial intermediary role of the comprehensive investment bank, promoted the industrial development with innovative services, and linked up a glittering science and innovation industrial chain.
On January 12, Tianyue advanced was listed on the science and innovation board. This high-tech enterprise focusing on the R & D and production of wide band gap semiconductor silicon carbide substrate materials is the first listed enterprise of the third generation semiconductor substrate materials in China, which is of great significance to the stable development of China’s semiconductor industry chain; On January 18, Maiwei bio landed on the scientific innovation board. Its new antibody coupled drug (ADC) targeting cell adhesion molecule nectin-4 is the second in the world and the first in China to enter clinical research. The new monoclonal antibody targeting interleukin receptor ST2 is the first new drug with the same target in China; On February 23, West Point pharmaceutical was listed on the gem. Its core products have significant competitive advantages in the field of anti anemia drugs and drugs for the treatment of mental disorders. It has China’s exclusive varieties of preparations and APIs and has formed patent protection. The integration advantage of “API + Preparation” is prominent
To overcome the impact of the epidemic, on March 16 and March 17, Haitong Securities Company Limited(600837) also successfully recommended Shaanxi Sirui new materials Co., Ltd., the leader in the subdivided field of copper based new materials, and Beijing Geling Shentong Information Technology Co., Ltd., the first computer vision AI enterprise in a shares, to be listed on the science and innovation board, pay close attention to the market positioning of “hard technology” and continue to serve the national science and technology innovation and development strategy.
In terms of giving full play to the role of “gatekeeper” of intermediary institutions, Haitong Securities Company Limited(600837) said that in the face of more diversified market participants, more diversified needs and a more comprehensive and stricter legal and regulatory system brought about by the comprehensive registration system reform, Haitong Securities Company Limited(600837) focused on deepening the reform of state-owned enterprises, adhering to the concept of steady and far-reaching development, compacting the main responsibility, and continuously controlling the quality and export of the capital market with a “zero tolerance” attitude. Give full play to all-round and integrated professional advantages, and “feel the pulse and consult” for counseling enterprises with in-depth understanding of integrated circuits, biomedicine and other fields and first-class sponsorship, underwriting, investment and research capabilities.
It is reported that in January and February this year, a total of 61 enterprises in the whole market completed the review of IPO applications at the meeting, corresponding to 32 sponsors, of which 55 passed the review, while the passing rate of Haitong Securities Company Limited(600837) ipo financing reached 100%P align = “center” build “Haitong brand” in the field of integrated circuits and medical health
The reporter learned from Haitong Securities Company Limited(600837) that in recent years, Haitong Securities Company Limited(600837) as a state-owned financial enterprise in Shanghai, has actively responded to the national strategy, shouldered the responsibility of “chain leader” of the industrial chain, focused on serving key enterprises in the field of national development strategy, carried out special actions to supplement and strengthen the chain, strengthen the coordination between upstream and downstream industries, and actively promoted the development of small, medium and micro enterprises.
especially in the field of investment banking, since the launch of the scientific innovation board and the pilot registration system, Haitong Securities Company Limited(600837) seized the opportunity of the reform and development of the registration system, continued to further promote the reform of state-owned enterprises, and successfully created a “Haitong brand” in the fields of integrated circuits and medical health.
According to statistics, from the establishment of the sci-tech innovation board to the end of February 2022, Haitong Securities Company Limited(600837) completed the issuance of 35 Sci-tech Innovation Board IPO projects, with a cumulative financing amount of nearly 120 billion yuan. It has worked intensively in the fields of new generation information technology, high-end equipment manufacturing and new materials, new energy and energy conservation and environmental protection, biomedicine and technical services, and completed a number of projects with great market influence.
The the whole industry chain of semiconductors, equipment, etc. Tianyue advanced, Aojie technology and chuangyao technology, which were recommended for listing in January this year, are leading enterprises in the semiconductor industry chain, further consolidating Haitong Securities Company Limited(600837) ‘s position as a leading brokerage in the integrated circuit industry.
The , Xi’An Manareco New Materials Co.Ltd(688550) materials and Miracll Chemicals Co.Ltd(300848) materials in the field of contract R & D and production outsourcing Organization (cdmo), and Hvsen Biotechnology Co.Ltd(300871) , in the field of animal medicine, Nanmo biology in the field of contract R & D outsourcing Organization (CRO), Zhonghong Pulin Medical Products Co.Ltd(300981) in the field of medical consumables, etc.
Haitong Securities Company Limited(600837) said that 2022 is the end of the three-year action of state-owned enterprise reform and regional comprehensive reform, and it is also a year of major strategic opportunities for Haitong Securities Company Limited(600837) . In the new year, Haitong Securities Company Limited(600837) will continue to deepen the specialization strategy in an all-round way, accelerate the pace of specialization in an all-round way, continue to force the “neck” projects of the three leading industries such as integrated circuit, artificial intelligence and biomedicine to be listed on the science and innovation board, make every effort to do a good job in financial service support, actively practice the financial responsibility, and provide high-quality innovative financial service solutions for real enterprises in Shanghai.
On the one hand, Haitong has gradually extended the absolute advantages established in the semiconductor field to new semiconductor materials, new fields and other fields of TMT. Beijing Tongmei and zhongjuxin, who assisted in applying for the IPO of the science and innovation board, have been accepted and have entered the market to serve more than 40 enterprises in related fields.
On the other hand, Haitong integrates biomedical resources, arranges many medical industry fields, strives for a significant increase in the number of influential projects and the market share, and further consolidates the “Haitong brand”.
At the same time, Haitong will actively summarize the successful experience of specialization in the two major fields of integrated circuits and medical health, explore and replicate to emerging fields such as new energy, new materials, high-end equipment, green and low-carbon, multi-point layout and comprehensively help the development of the real economy.
